Shares of KITS Eyecare, a Canadian small-cap company that makes eyeglasses and contact lenses, rose more than 9% on the Toronto Stock Exchange yesterday, November 11. The company reported record sales for the week and flagged a "strong" fourth quarter and full year.
Details
KITS shares gained 9.2% to CAD13.66 on the Toronto Stock Exchange yesterday following the announcement of a record sales performance for the week of November 1-8. Sales rose 27% year over year to CAD4.48 million, with repeat customers accounting for 66% of the total.
Cofounder and CEO Roger Hardy highlighted “strong momentum into the holiday season, supported by continued execution across value, selection, and fast delivery. Key pillars that position us to deliver a strong Q4 and full year 2025." KITS has previously guided for fourth-quarter revenue of CAD52-54 million.
About KITS
Founded in 2018 by Hardy and Joseph Thompson and Sabrina Liak, KITS began as a manufacturer of corrective lenses before expanding into eyeglass production.
The company now positions itself as a digital vision-care platform, offering online eye exams, eyeglasses, and contact lenses. Its vertically integrated model – design, manufacturing, and fulfillment – enables same-day production and next-day delivery across Canada, which is a core element of its strategy.
In the third quarter of 2025, KITS reported revenue of CAD52.4 million, up 25.1% year over year, while net income rose more than sevenfold to CAD1.9 million. Adjusted EBITDA for the first nine months of the year increased over 150% to CAD8.9 million. Even though the company flagged these as records, the market reaction was muted, as KITS shares gained only 2.5% on November 7, the day after the earnings.
Stock performance
According to Investing.com, KITS has seven “buy” ratings from analysts versus no “sell” recommendations. The average target price of CAD22.64 per share implies upside of nearly 66% from the last closing price.
The AI translation of this story was reviewed by a human editor.
